Related Experiment Video
Updated: Feb 6, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
RNA-mediated therapies in myotonic dystrophy
Sarah J Overby1, Estefanía Cerro-Herreros1, Beatriz Llamusi1
1University of Valencia, Interdisciplinary Research Structure for Biotechnology and Biomedicine (ERI BIOTECMED), Valencia, Spain; Translational Genomics Group, Incliva Health Research Institute, Valencia, Spain; Joint Unit Incliva-CIPF, Valencia, Spain.
Myotonic dystrophy 1 (DM1) is a neuromuscular disease caused by toxic repeat expansions. RNA-targeted therapies show promise in restoring protein function and alleviating symptoms in DM1 models.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Myotonic dystrophy 1 (DM1) is a multisystemic neuromuscular disorder.
- It stems from a 'CTG' repeat expansion in the DMPK gene.
- This expansion leads to toxic RNA, MBNL protein sequestration, and disease pathology.
Purpose of the Study:
- To investigate RNA-mediated technologies for DM1 therapeutics.
- To explore the restoration of MBNL protein function in DM1.
Main Methods:
- Utilizing antisense and RNA-targeting strategies.
- Applying these methods to DM1 cellular and mouse models.
- Evaluating the alleviation of pathogenic phenotypes.
Main Results:
- Targeting toxic repeat mRNA transcripts successfully restored MBNL protein function.
- RNA-mediated technologies demonstrated promising therapeutic potential.
- Pathogenic phenotypes were alleviated in DM1 models.
Conclusions:
- RNA-mediated technologies are a viable therapeutic strategy for DM1.
- Restoring MBNL protein function is key to treating DM1.
- These approaches hold promise for human DM1 therapeutics.
Related Concept Videos
Satellite Stem Cells and Muscular Dystrophy
RNA Polymerase II Accessory Proteins
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Structure
The basic structure of RNA consists of a five-carbon sugar and one of four nitrogenous bases. Although most RNA is single-stranded, it can form complex secondary and tertiary structures. Such structures play essential roles in the regulation of transcription and translation.
Different Types of RNA Have the Same Basic Structure
There are three main types of ribonucleic acid (RNA): messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). All three RNA types consist of a...
Gene Therapy
RNA Stability

